Evaluation of platelets in heart failure: Is platelet activity related to etiology, functional class, or clinical outcomes?
- 1 June 2002
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 143 (6) , 1068-1075
- https://doi.org/10.1067/mhj.2002.121261
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of Reteplase and Alteplase on Platelet Aggregation and Major Receptor Expression During the First 24 Hours of Acute Myocardial Infarction TreatmentJournal of the American College of Cardiology, 1998
- PFA-100™ System: A New Method for Assessment of Platelet DysfunctionSeminars in Thrombosis and Hemostasis, 1998
- Agonist-activated αvμ3 on Platelets and Lymphocytes Binds to the Matrix Protein OsteopontinJournal of Biological Chemistry, 1997
- Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin ( ) receptor?Molecular Aspects of Medicine, 1997
- Does aspirin cause acute or chronic renal failure in experimental animals and in humans?American Journal of Kidney Diseases, 1996
- Relationship between hemostatic abnormalities and neuroendocrine activity in heart failureAmerican Heart Journal, 1994
- Platelet function, thrombin and fibrinolytic activity in patients with heart failureEuropean Heart Journal, 1993
- Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in congestive heart failure: inhibition by sodium nitroprusside.Circulation, 1979